FBI LOGO TM.png
COVID-19 Diagnostics Market Size [2020-2027] | is Projected to Reach USD 11.40 Billion, exhibiting a CAGR of 7.9%
October 21, 2021 07:21 ET | Fortune Business Insights
Pune, India, Oct. 21, 2021 (GLOBE NEWSWIRE) -- The global COVID-19 diagnostics market size is projected to reach USD 11.40 billion by 2027, exhibiting a CAGR of 7.9% during the forecast period. ...
researchdrivelogo.jpg
Global MICE Industry Expected to Generate a Revenue of $1,619.3 Billion by 2028, Growing at a CAGR of 5.9% from 2021-2028 - Exclusive Report [Pages-168] by Research Dive
October 20, 2021 09:00 ET | Research Dive
New York, USA, Oct. 20, 2021 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global MICE industry is predicted to generate a revenue of $1,619.3 billion by 2028, growing...
researchdrivelogo.jpg
Global Biological Wastewater Treatment Industry to Hit $11,963.1 Million by 2026, Rising with a CAGR of 5.9% during the COVID-19 Upheaval - Exclusive Report by Research Dive
October 18, 2021 08:59 ET | Research Dive
New York, USA, Oct. 18, 2021 (GLOBE NEWSWIRE) -- A latest report on the global biological wastewater treatment market published by Research Dive sheds light on the impact of COVID-19 pandemic on the...
researchdrivelogo.jpg
Global Organ Care System for Liver Market Predicted to Garner a Revenue of $42.7 Million at a CAGR of 9.3% during the Forecast Period, 2019-2026 COVID-19 Disaster - Exclusive Report by Research Dive
September 21, 2021 09:35 ET | Research Dive
New York, USA, Sept. 21, 2021 (GLOBE NEWSWIRE) -- According to a recent report by Research Dive, the global organ care system for liver market is forecasted to reach $42.7 million by the end of...
ADPT new logo.jpg
Adaptive Biotechnologies to Present New SARS-CoV-2 Data from its Immune Medicine Platform During IDWeek 2021
September 16, 2021 08:03 ET | Adaptive Biotechnologies
SEATTLE, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...
researchdrivelogo.jpg
Global Contract Development and Manufacturing Organization Market Expected to Generate a Revenue of $315.7 Billion by 2026, Growing at a CAGR of 12.4% from 2019-2026 COVID-19 Impact - Exclusive Report by Research Dive
September 15, 2021 09:01 ET | Research Dive
New York, USA, Sept. 15, 2021 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global contract development and manufacturing organization market is expected to generate a...
researchdrivelogo.jpg
Global Medical Tourism Market Expected to Generate a Revenue of $142.2 Billion by 2026, Growing at a CAGR of 11.7% from 2019-2026 COVID-19 impact - Exclusive Report by Research Dive
September 14, 2021 09:01 ET | Research Dive
New York, USA, Sept. 14, 2021 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global medical tourism market is expected to generate a revenue of $142.2 billion by 2026,...
FBI LOGO TM.png
COVID-19 Diagnostics Market Size | to Reach USD 9.20 Billion by 2028; Increasing Prevalence of Positive Cases to Bolster Service Demand: Fortune Business Insights™
September 01, 2021 06:20 ET | Fortune Business Insights
Pune, India, Sept. 01, 2021 (GLOBE NEWSWIRE) -- The global COVID-19 diagnostics market size was USD 16.05 billion in 2020. The market is projected to drop from USD 20.05 billion in 2021 to USD 9.20...
Microbiologics Launches SARS-CoV-2 Whole Virus Antigen Controls for Point-of-Care COVID-19 Diagnostics
August 31, 2021 10:02 ET | Microbiologics
St. Cloud, Minnesota, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Microbiologics has launched a new SARS-CoV-2 quality control (QC) product designed for use with antigen point-of-care (POC) methods. The...
Axim-Sapphire_Logo_-04 (1).png
AXIM® Biotechnologies’ Manufacturing Partner Empowered Diagnostics Files Amended Emergency Use Authorization with FDA for its Rapid COVID-19 Neutralizing Antibody Test in Whole Blood at Point-of-Care Locations
August 30, 2021 09:00 ET | AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, Aug. 30, 2021 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting...